BeStock  
Stocks › Biotechnology › IDYA

IDEAYA Biosciences IDYA

US equityMarket cap rank #2556Biotechnology
$25.56 −$0.61 (-2.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.56 0.00%
Open$25.83
Prev close$26.17
Day range$25.46 – $26.87
Volume1.11M
Market cap$2.47B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$10.24M-95.1% YoY
Operating profit-$137.63M-226.9% YoY
Net profit-$125.75M-205.5% YoY
Diluted EPS-$1.22-191.7% YoY
Free cash flow-$93.75M-165.9% YoY
Operating cash flow-$93.48M

Revenue, last 8 quarters

$7.0MDec '24$0.0Mar '25$0.0Jun '25$207.8MSep '25$10.9MDec '25$6.6MMar '26$8.9MJun '26$10.2MSep '26

Net profit, last 8 quarters

$-130.3MDec '24$-72.2MMar '25$-77.5MJun '25$119.2MSep '25$-83.3MDec '25$-98.5MMar '26$-112.5MJun '26$-125.7MSep '26

Diluted EPS by quarter

-1.49Dec '24-0.82Mar '25-0.88Jun '251.33Sep '25-0.94Dec '25-1.11Mar '26-1.22Jun '26-1.22Sep '26

Free cash flow by quarter

$-122.8MDec '24$-61.7MMar '25$-63.1MJun '25$142.2MSep '25$-90.8MDec '25$-76.1MMar '26$-89.1MJun '26$-93.8MSep '26

Annual revenue

$19.5MFY20$27.9MFY21$50.9MFY22$23.4MFY23$7.0MFY24$218.7MFY25

Profitability & balance sheet

Operating margin-1,267.3%
Net margin-1,149.6%
Return on equity-38.5%
Return on assets-35.0%
Return on invested capital-41.3%
Current ratio9.04
Liabilities / assets10.2%
Cash & investments$838.54M
Total debt$27.55M
Net cash (debt)$810.99M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $10.24M $8.86M $6.56M $218.71M $10.88M
Total Operating Revenue $10.24M $8.86M $6.56M $218.71M $10.88M
Operating Expense $147.87M $131.15M $115.10M $378.02M $105.45M
Selling and Admin Expenses $26.30M $22.46M $19.38M $63.32M $18.85M
-General & Admin Expense $26.30M $22.46M $19.38M $63.32M $18.85M
Research & Development $121.58M $108.69M $95.73M $314.70M $86.60M
Operating Profit -$137.63M -$122.29M -$108.54M -$159.31M -$94.57M
Net Non-Operating Interest Income (Expense) $11.88M $9.84M $10.01M $45.62M $11.30M
Non-Operating Interest Income $11.88M $9.84M $10.01M $45.62M $11.30M
Pretax Profit -$125.75M -$112.45M -$98.54M -$113.70M -$83.27M
Net Profit -$125.75M -$112.45M -$98.54M -$113.70M -$83.27M
Profit from Continuing Operations -$125.75M -$112.45M -$98.54M -$113.70M -$83.27M
Net Income to Parent Company -$125.75M -$112.45M -$98.54M -$113.70M -$83.27M
Net Income to Common Stockholders -$125.75M -$112.45M -$98.54M -$113.70M -$83.27M
Basic EPS -$1.22 -$1.22 -$1.11 -$1.28 -$0.94
Diluted EPS -$1.22 -$1.22 -$1.11 -$1.28 -$0.94

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.22B $1.31B $1.03B $1.11B $1.11B
Total Current Assets $871.97M $864.03M $696.11M $666.73M $666.73M
Cash and Cash Equivalents & Short-Term Investments $838.54M $828.96M $671.20M $639.39M $639.39M
-Cash and Cash Equivalents $261.45M $272.59M $157.52M $112.83M $112.83M
-Short Term Investments $577.09M $556.37M $513.68M $526.56M $526.56M
Receivables $10.24M $15.42M $6.56M $5.97M $5.97M
-Other Receivables $10.24M $15.42M $6.56M $5.97M $5.97M
Other Current Assets $23.18M $19.65M $18.35M $21.37M $21.37M
Total Non-Current Assets $344.06M $445.67M $334.24M $442.60M $442.60M
Net PPE $29.58M $30.46M $31.25M $31.29M $31.29M
-Gross PPE $45.83M $46.09M $46.19M $45.54M $45.54M
-Accumulated Depreciation -$16.25M -$15.63M -$14.95M -$14.26M -$14.26M
Investments and Advances $312.29M $413.93M $301.71M $410.30M $410.30M
-Available for Sale Securities $312.29M $413.93M $301.71M $410.30M $410.30M
Other Non-Current Assets $2.19M $1.28M $1.28M $1.02M $1.02M
Total Liabilities $123.96M $110.79M $93.08M $86.39M $86.39M
Total Current Liabilities $96.41M $82.68M $64.83M $58.82M $58.82M
Payables $22.04M $30.51M $20.74M $17.58M $17.58M
-Accounts Payable $22.04M $30.51M $20.74M $17.58M $17.58M
Current Accrued Expenses $72.22M $50.98M $43.75M $40.89M $40.89M
Short-Term Debt and Capital Lease Obligation $2.15M $1.19M $350,000.00 $339,000.00 $339,000.00
-Current Capital Lease Obligation $2.15M $1.19M $350,000.00 $339,000.00 $339,000.00
Total Non-Current Liabilities $27.55M $28.12M $28.25M $27.58M $27.58M
Long Term Debt and Capital Lease Obligation $27.55M $28.12M $28.25M $27.58M $27.58M
-Long Term Capital Lease Obligation $27.55M $28.12M $28.25M $27.58M $27.58M
Total Equity $1.09B $1.20B $937.27M $1.02B $1.02B
Stockholders' Equity $1.09B $1.20B $937.27M $1.02B $1.02B
Capital Stock $10,000.00 $10,000.00 $9,000.00 $9,000.00 $9,000.00
-Common Stock $10,000.00 $10,000.00 $9,000.00 $9,000.00 $9,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.17B $2.15B $1.77B $1.76B $1.76B
Retained Earnings -$1.07B -$947.53M -$835.08M -$736.54M -$736.54M
Gains/Losses Not Affecting Retained Earnings -$4.88M -$1.67M -$494,000.00 $2.27M $2.27M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$93.48M -$88.21M -$75.17M -$71.10M -$90.50M
Net cash flow from continuing operations -$93.48M -$88.21M -$75.17M -$71.10M -$90.50M
Net Income from Continuing Operations -$125.75M -$112.45M -$98.54M -$113.70M -$83.27M
Depreciation & Depletion & Amortization $1.03M $1.12M $1.14M $4.59M $1.20M
Change in Working Capital $14.72M $7.48M $8.90M $1.87M -$18.69M
-Change in Prepaid Assets -$4.57M -$1.05M $3.03M -$7.84M -$5.56M
-Change in Payables and Accrued Expense $13.72M $16.68M $5.78M $13.12M -$5.66M
-Change in Other Current Liabilities $396,000.00 $707,000.00 $686,000.00 $2.56M $669,000.00
-Change In Other Working Capital $5.18M -$8.86M -$587,000.00 -$5.97M -$8.14M
Net cash flow from investing $78.65M -$155.93M $118.95M $69.98M -$97.53M
Net Cash Flow from Continuing Investing Activities $78.65M -$155.93M $118.95M $69.98M -$97.53M
Net PPE Purchase and Sale -$273,000.00 -$866,000.00 -$967,000.00 -$2.37M -$333,000.00
Net Investment Purchase and Sale $78.92M -$155.07M $119.92M $72.34M -$97.19M
Financing Cash Flow $3.70M $359.21M $1.18M $29.78M $2.13M
Net Cash Flow from Continuing Financing Activities $3.70M $359.21M $1.18M $29.78M $2.13M
Net Common Stock Issuance -$1.18M $216.44M -$9,000.00 $24.86M -$46,000.00
Proceeds from Stock Option Exercised $4.88M $142.77M $1.19M $4.92M $2.18M
Ending Cash Balance $262.73M $273.87M $158.80M $113.84M $113.84M
Net Change in Cash -$11.14M $115.07M $44.96M $28.66M -$185.89M
Beginning Cash Balance $273.87M $158.80M $113.84M $85.18M $299.73M
Free Cash Flow -$93.75M -$89.08M -$76.14M -$73.47M -$90.83M
-Change in Receivables – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on IDYA.

Sign in to join the discussion.

Scroll to Top